Press Releases
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 12, 2020-- U.S. Food and Drug Administration (FDA) Grants Conditional Approval for New Brand Name - Phexxi™ --
-
Mar 3, 2020-- Conference Call Scheduled for 11:00 a.m. EDT --
-
Feb 26, 2020- Distinguished Career at the U.S. Food and Drug Administration in CDER and the Office of Women's Health; Significant Industry and Regulatory Expertise -
-
Dec 18, 2019- Assigns PDUFA Goal Date of May 25, 2020 -
-
Dec 2, 2019- AMPREVENCE Study Met Primary and Secondary Endpoints - a 50% Relative Risk Reduction in Chlamydia Infection and a 78% Relative Risk Reduction in Gonorrhea Infection Compared to Placebo -
-
Nov 26, 2019- Submission Supported by Phase 3 AMPOWER Data -
-
Nov 14, 2019- San Diego Business Journal Recognizes the City's Top 15 Female Business Leaders -